Cytisinicline and Tobacco Cessation

The pharmacotherapy for tobacco cessation continues to evolve with new treatment options. Join host, Geoff Wall, with guest, Jake Galdo, as they discuss the role of the pharmacy team in tobacco cessation. The GameChangerPharmacotherapy alone may not be sufficient for tobacco cessation - counseling and support are often required. A new medication, cytisinicline, may provide additional options for treatment. HostGeoff Wall, PharmD, BCPS, FCCP, BCGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthGuestJake Galdo, PharmD, MBA, BCPS, BCGPCourse Content and Developer, CEimpactManaging Network Facilitator, CPESN Health EquityCEO, Seguridad ReferenceRigotti NA, Benowitz NL, Prochaska J, et al. Cytisinicline for Smoking Cessation: A Randomized Clinical Trial. JAMA. 2023 Jul 11;330(2):152-160. doi: 10.1001/jama.2023.10042. PMID: 37432430; PMCID: PMC10336611.https://jamanetwork.com/journals/jama/article-abstract/2807079 Pharmacist Members, REDEEM YOUR CPE HERE! Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)CPE Information Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Discuss obstacles to effective tobacco cessation therapy2. Compare and contrast cytisinicline with other pharmacotherapy agents for tobacco cessation0.05 CEU/0.5 HrUAN: 0107-0000-23-287-H01-PInitial release date: 8/14/2023Expiration date: 8/14/2024Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram